• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC PFS 8/ML (3X2ML); ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC PFS 8/ML (3X2ML); ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number CRSP012Z
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fall (1848); Bone Fracture(s) (1870)
Event Date 01/17/2023
Event Type  Injury  
Event Description
The patient indicated on the portal order that she "had a gallstone removed outpatient surgery (b)(6) 2023; i had my gallbladder removed outpatient surgery (b)(6) 2023 tripped and fell and fractured my humerus bone near my right shoulder in 2 places.Bone is mending and i am currently going outpatient therapy twice weekly.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC PFS 8/ML (3X2ML)
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key17031582
MDR Text Key316318604
Report NumberMW5117989
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot NumberCRSP012Z
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age66 YR
Patient SexFemale
-
-